Skip to main content Accessibility help
×
Home
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 1
  • Print publication year: 2012
  • Online publication date: September 2012

Chapter 4 - Functional anatomy of the FDG image

from Part I - General concepts of PET and PET/CT imaging

Summary

The physiologic basis of FDG uptake

18F-fluorodeoxyglucose (FDG) is an index molecule for glucose metabolism, a highly complex physiologic process. It is practically a truism that malignant cells proliferate rapidly, and thus tend to have a high metabolic rate (1, 2). However, this statement conceals as much as it reveals. The “metabolism” depicted by a PET scan image cannot be treated as a simple continuum, with benign and inert tissues at the low end (white = “good”), and rampant malignancies at the high end (black = “bad”). There are many kinds of metabolism, and glucose is not the only metabolic currency. Nor is glucose metabolism uniform; it has many competing pathways, often within the same cell. These include both catabolic (energy-producing) or anabolic (energy-consuming) processes, such as the pentose phosphate pathway.

FDG uptake does not directly correspond to the presence or activity of any single molecular target. Every count in every pixel on an ordinary PET scan is a summation of numerous factors, including delivery of tracer molecules to the tissues (plasma input function) and the microscopic and macroscopic architecture of the tissue itself. These are not academic trivia; intimate understanding of these factors is essential for accurate interpretation of PET images. Oversimplification is the most common and perhaps the most dangerous error in reading PET scans.

References
Warburg, O.On respiratory impairment in cancer cellsScience 1956 124 269
Warburg, OWind, FNegelein, E.The metabolism of tumors in the bodyJ Gen Physiol 1927 8 519
Carruthers, A.Facilitated diffusion of glucosePhysiol Rev 1990 70 1135
Uldry, MThorens, B.The SLC2 family of facilitated hexose and polyol transportersPflugers Arch 2004 447 480
Crane, RKDorando, FC.On the mechanism of Na+-dependent glucose transportAnn N Y Acad Sci 1980 339 46
Moran, JKLee, HBBlaufox, MD.Optimization of urinary FDG excretion during PET imagingJ Nucl Med 1999 40 1352
Anderson, JWHerman, RHTyrrell, JBCohn, RM.Hexokinase: a compartmented enzymeAm J Clin Nutr 1971 24 642
Purich, DLFromm, HJRudolph, FB.The hexokinases: kinetic, physical, and regulatory propertiesAdv Enzymol Relat Areas Mol Biol 1973 39 249
Torizuka, TTamaki, NInokuma, TIn vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PETJ Nucl Med 1995 36 1811
Britz-Cunningham, SHMillstine, JWGerbaudo, VH.Improved discrimination of benign and malignant lesions on FDG PET/CT, using comparative activity ratios to brain, basal ganglia, or cerebellumClin Nucl Med 2008 33 681
Boerner, ARVoth, ETheissen, PGlucose metabolism of the thyroid in autonomous goiter measured by F-18-FDG-PEExp Clin Endocrinol Diabetes 2000 108 191
Park, CHLee, EJKim, JKJoo, HJJang, JS.Focal F-18, FDGuptake in a nontoxic autonomous thyroid noduleClin Nucl Med 2002 27 136
Ramos, CDChisin, RYeung, HWLarson, SMMacapinlac, HA.Incidental focal thyroid uptake on FDG positron emission tomographic scans may represent a second primary tumorClin Nucl Med 2001 26 193
Kang, KWKim, SKKang, HSPrevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjectsJ Clin Endocrinol Metab 2003 88 4100
Gerbaudo, VHJulius, B.Anatomo-metabolic characteristics of atelectasis in F-18 FDG-PET/CT imagingEur J Radiol 2007 64 401
Kamel, EMMcKee, TACalcagni, MLOccult lung infarction may induce false interpretation of 18F-FDG PET in primary staging of pulmonary malignanciesEur J Nucl Med Mol Imaging 2005 32 641
Nguyêñ, VTMossberg, KATewson, TJTemporal analysis of myocardial glucose metabolism by 2-[18F]fluoro-2-deoxy-D-glucoseAm J Physiol 1990 259 H1022
Choi, YBrunken, RCHawkins, RAFactors affecting myocardial 2-[F-18]fluoro-2-deoxy-D-glucose uptake in positron emission tomography studies of normal humansEur J Nucl Med 1993 20 308
Gontier, EFourme, EWartski, MHigh and typical 18F-FDG bowel uptake in patients treated with metforminEur J Nucl Med Mol Imaging 2008 35 95
Ozülker, TOzülker, FMert, MOzpaçaci, T.Clearance of the high intestinal (18)F-FDG uptake associated with metformin after stopping the drugEur J Nucl Med Mol Imaging 2010 37 1011
Oh, JRSong, HCChong, AImpact of medication discontinuation on increased intestinal FDG accumulation in diabetic patients treated with metforminAm J Roentgenol 2010 195 1404
Lerman, HMetser, UGrisaru, DNormal and abnormal 18F-FDG endometrial and ovarian uptake in pre- and postmenopausal patients: assessment by PET/CTJ Nucl Med 2004 45 266
Parysow, OMollerach, AMJager, VLow-dose oral propranolol could reduce brown adipose tissue F-18 FDG uptake in patients undergoing PET scansClin Nucl Med 2007 32 351
Williams, GKolodny, GM.Method for decreasing uptake of 18F-FDG by hypermetabolic brown adipose tissue on PETAm J Roentgenol 2008 190 1406
Aluise, CDSultana, RTangpong, JChemo brain (chemo fog) as a potential side effect of doxorubicin administration: role of cytokine-induced, oxidative/nitrosative stress in cognitive dysfunctionAdv Exp Med Biol 2010 678 147